Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
The International Journal of Biochemistry & Cell Biology
|
May 15, 2019
GPER1 influences cellular homeostasis and cytostatic drug resistance via influencing long chain ceramide synthesis in breast cancer cells
Marthe-Susanna Wegner, Lisa Gruber, Nina Schömel, et al.
Frontiers in Immunology
|
June 6, 2018
NoxO1 Controls Proliferation of Colon Epithelial Cells
Franziska Moll, Maria Walter, Flávia Rezende, et al.
Plos One
|
September 29, 2015
Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma
G-Andre Banat, Aleksandra Tretyn, Soni Savai Pullamsetti, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 9, 2021
Increased glucosylceramide production leads to decreased cell energy metabolism and lowered tumor marker expression in non-cancerous liver cells
Marthe-Susanna Wegner, Nina Schömel, Ellen M Olzomer, et al.
Oncotarget
|
April 15, 2015
MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer
Catherine Olesch, Weixiao Sha, Carlo Angioni, et al.
The Journal of Clinical Investigation
|
July 15, 2020
S1PR4 ablation reduces tumor growth and improves chemotherapy via CD8+ T cell expansion
Catherine Olesch, Evelyn Sirait-Fischer, Matthias Berkefeld, et al.
The Journal of Experimental Medicine
|
July 26, 2017
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
Benjamin Weichand, Rüdiger Popp, Sarah Dziumbla, et al.
Cancer Research
|
April 15, 2022
Phosphatidylserine Synthase PTDSS1 Shapes the Tumor Lipidome to Maintain Tumor-Promoting Inflammation
Divya Sekar, Christina Dillmann, Evelyn Sirait-Fischer, et al.
Journal for Immunotherapy of Cancer
|
November 14, 2023
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy
Christina Kober, Julian Roewe, Norbert Schmees, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
The International Journal of Biochemistry & Cell Biology
|
May 15, 2019
GPER1 influences cellular homeostasis and cytostatic drug resistance via influencing long chain ceramide synthesis in breast cancer cells
Marthe-Susanna Wegner, Lisa Gruber, Nina Schömel, et al.
Frontiers in Immunology
|
June 6, 2018
NoxO1 Controls Proliferation of Colon Epithelial Cells
Franziska Moll, Maria Walter, Flávia Rezende, et al.
Plos One
|
September 29, 2015
Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma
G-Andre Banat, Aleksandra Tretyn, Soni Savai Pullamsetti, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 9, 2021
Increased glucosylceramide production leads to decreased cell energy metabolism and lowered tumor marker expression in non-cancerous liver cells
Marthe-Susanna Wegner, Nina Schömel, Ellen M Olzomer, et al.
Oncotarget
|
April 15, 2015
MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer
Catherine Olesch, Weixiao Sha, Carlo Angioni, et al.
The Journal of Clinical Investigation
|
July 15, 2020
S1PR4 ablation reduces tumor growth and improves chemotherapy via CD8+ T cell expansion
Catherine Olesch, Evelyn Sirait-Fischer, Matthias Berkefeld, et al.
The Journal of Experimental Medicine
|
July 26, 2017
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
Benjamin Weichand, Rüdiger Popp, Sarah Dziumbla, et al.
Cancer Research
|
April 15, 2022
Phosphatidylserine Synthase PTDSS1 Shapes the Tumor Lipidome to Maintain Tumor-Promoting Inflammation
Divya Sekar, Christina Dillmann, Evelyn Sirait-Fischer, et al.
Journal for Immunotherapy of Cancer
|
November 14, 2023
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy
Christina Kober, Julian Roewe, Norbert Schmees, et al.
Page
of 2